Well, here's a little info re Celltech from WallStreetJournal briefing book.
Celltech Group Plc
Celltech Plc is a a research pharmaceutical company involved in the
discovery and development of novel therapeutic products for human use. During 1998 the group has made continued progress with its two leading product candidates CMA676 FOR Acute Myeloid Leukaemia and CDP571 for Crohn's disease which are in late phase clinical studies.
Address: 216 BATH ROAD
SLOUGH, BERKSHIRE SL1 4EN
UNITED KINGDOM
Phone:
+44 1753 534655
Fax:
+44 1753 536632
Chairman: J.B.H. JACKSON
Chief Executive Officer: P.J. FELLNER
Employees: 218
Market Capitalization - Current: 344,194,784
Common Shares Outstanding -
Current: 76,915,040
Earnings per Share - Last 12 Months: -0.15
Date of Last 12 Months EPS: 03/31/1999
Book Value Per Share - Current: 0.48
Dividends Per Share - Last 12 Months: 0
Total Assets: 49,000,000
Total Liabilities: 7,300,000
Common Equity: 36,800,000
Net Sales or Revenues: 11,700,001
All cash values are in millions of Pounds Sterling
Ticker Symbol:
U.CEL
Exchange:
LONDON
Copyright © 1999 Worldscope
Where do you get your info re Chiroscience? Where'd you learn about it in the first place? Several places I look are: Financial Times (you have to sign up, but it's free at www.ft.com) Yahoo-UK/Ireland financial (http://finance.uk.yahoo.com) and a new site here in US covering UK stocks (uk-iNvest.com).
Has anyone found (or even looked) for info on CellTech? |
